Public Consultations are held regularly as a form of soliciting public input on the draft documents produced by EUnetHTA within the framework of implementing the EUnetHTA Joint Action 2 grant agreement and 3-year EUnetHTA Joint Action 2 Work Plan. Announcements of the public consultations are made in the News section of this website.

Properly submitted contributions will be made public on the EUnetHTA public website within a month after the closing date of the public consultation (unless the author has explicitly opposed publication of their contribution or the contributions do not address the draft documents put forward for public consultation or contain complaints against institutions, personal accusations, irrelevant or offensive statements or material). The name of the author, his affiliation, and date of the submission’s receipt will be disclosed when the contribution is made public.

More detailed instructions are provided on the news dedicated for each specific public consultation.

We are pleased to announce that as of today, 14 October, 2015, the draft methodological guideline “Therapeutic medical devices”, produced within WP7 - Subgroup 3, has entered the public consultation phase.
We are pleased to announce that the eight adapted methodological guidelines for Relative Effectiveness Assessment (REA) developed in JA1 and revised by WP7 - Subgroup 3 in JA2, are ready for public consultation..
We are pleased to announce that as of today the HTA Core Model for rapid Relative Effectiveness Assessments, by Work Package 5, has entered the public consultation phase.
WP7 Subgroup 2 is pleased to announce the public consultation on the Core protocol Pilot for Additional Evidence Generation (AEG).
We are pleased to announce that as of today the Draft Project Plan regarding the production of a Rapid Relative Effectiveness Assessment of new pharmaceuticals for the treatment of chronic hepatitis C by Work Package 5 has entered the public consultation phase.